NYSE:BAXMedical Equipment
The Bull Case For Baxter International (BAX) Could Change Following Hurricane Hit And Guidance Cut
In October 2025, Baxter International reported third-quarter adjusted earnings per share that exceeded expectations but delivered revenue below forecasts, while also cutting its full-year earnings and sales growth guidance due to hurricane-related disruptions at its North Cove facility and ongoing issues in its infusion pump portfolio.
This combination of operational setbacks and reduced outlook has reinforced investor concerns about the resilience of Baxter’s core medical products business...